RankingsPricing
  1. US-listed companies
  2. IONIS PHARMACEUTICALS INC
  3. Financials
  4. Total cash & short-term investments

IONIS PHARMACEUTICALS INCIONS

Market cap
$12.3B
P/E ratio
SummaryFinancials
Period EndTotal cash & short-term investments (Million USD)YoY (%)
Dec 31, 20242,298-1.44%
Dec 31, 20232,331+17.33%
Dec 31, 20221,987-40.88%
Dec 31, 20213,361+77.59%
Dec 31, 20201,892-24.29%
Dec 31, 20192,500+19.94%
Dec 31, 20182,084+103.78%
Dec 31, 20171,023+53.74%
Dec 31, 2016665-14.63%
Dec 31, 2015779+6.91%
Dec 31, 2014729+10.97%
Dec 31, 2013657+75.40%
Dec 31, 2012374+8.96%
Dec 31, 2011344-60.71%
Dec 31, 2010875

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)